Lung Cancers Completed Phase 2 Trials for Matuzumab (DB05101)

Also known as: LUng Cancer / Cancer, Lung / Lung neoplasm malignant / Lung cancer NOS / Cancer of lung / Ca lung

IndicationStatusPhase
DBCOND0072929 (Lung Cancers)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00111839Effects of Matuzumab in Combination With Pemetrexed for the Treatment of Advanced Lung CancerTreatment